1. Home
  2. ENTA vs ACCO Comparison

ENTA vs ACCO Comparison

Compare ENTA & ACCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Enanta Pharmaceuticals Inc.

ENTA

Enanta Pharmaceuticals Inc.

HOLD

Current Price

$12.66

Market Cap

382.7M

Sector

Health Care

ML Signal

HOLD

Logo Acco Brands Corporation

ACCO

Acco Brands Corporation

HOLD

Current Price

$3.90

Market Cap

361.7M

ML Signal

HOLD

Company Overview

Basic Information
Metric
ENTA
ACCO
Founded
1995
1893
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Publishing
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
382.7M
361.7M
IPO Year
2012
2005

Fundamental Metrics

Financial Performance
Metric
ENTA
ACCO
Price
$12.66
$3.90
Analyst Decision
Strong Buy
Buy
Analyst Count
5
1
Target Price
$20.40
$5.00
AVG Volume (30 Days)
172.5K
730.4K
Earning Date
05-11-2026
04-30-2026
Dividend Yield
N/A
9.26%
EPS Growth
29.93
141.51
EPS
N/A
0.20
Revenue
$102,814,000.00
$1,524,700,000.00
Revenue This Year
$7.76
$3.10
Revenue Next Year
N/A
$0.89
P/E Ratio
N/A
$19.48
Revenue Growth
16.48
N/A
52 Week Low
$6.44
$2.81
52 Week High
$17.15
$4.30

Technical Indicators

Market Signals
Indicator
ENTA
ACCO
Relative Strength Index (RSI) 51.14 51.91
Support Level $11.92 $3.81
Resistance Level $13.97 $4.21
Average True Range (ATR) 0.79 0.11
MACD 0.13 -0.02
Stochastic Oscillator 73.47 35.59

Price Performance

Historical Comparison
ENTA
ACCO

About ENTA Enanta Pharmaceuticals Inc.

Enanta Pharmaceuticals Inc is a biotechnology company that uses a chemistry-based drug discovery approach to develop small-molecule candidates for virology and immunology applications. It focuses on Virology and Immunology. Its active development programs in virology are focused on respiratory syncytial virus, or RSV, and SARS-CoV-2, and Hepatitis B virus. In immunology, the company is engaged in designing and developing potent and selective, oral small molecule inhibitors for the treatment of type 2 inflammatory disease. The company has collaborated with AbbVie, which markets its protease inhibitor paritaprevir, with additional inhibitors in development. The company generates the majority revenue in the form of royalty revenue.

About ACCO Acco Brands Corporation

ACCO Brands Corp is a consumer, technology and business branded products company providing brands and product solutions used in schools, homes and at work. Its brands include At-A-Glance, Barrilito, Buro, Esselte, Five Star, Foroni, GBC, Hilroy, Kensington, Leitz, Mead, PowerA, Quartet, Rapid, Swingline and Tilibra. The Company's product categories include gaming and computer accessories, storage and organization, notebooks, shredding, laminating and binding machines, dry erase boards and do-it-yourself tools. The Company operates through two segments, Americas and International. Americas includes the U.S., Canada, Brazil, Mexico and Chile, and International includes EMEA, Australia, New Zealand and Asia. Its products are sold in the U.S., Europe, Australia, Canada, Brazil and Mexico.

Share on Social Networks: